Biotron Limited
BITRF
$0.01
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 11.58% | 13.35% | 11.94% | -29.16% | -48.37% |
| Total Revenue | 11.58% | 13.35% | 11.94% | -29.16% | -48.37% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 11.58% | 13.35% | 11.94% | -29.16% | -48.37% |
| SG&A Expenses | -2.67% | -9.20% | -16.37% | -6.94% | 5.42% |
| Depreciation & Amortization | -38.87% | -23.08% | -8.90% | -9.27% | -9.29% |
| Other Operating Expenses | -33.33% | -34.48% | -36.22% | -64.90% | -74.35% |
| Total Operating Expenses | -44.42% | -23.54% | -0.54% | 8.57% | 19.18% |
| Operating Income | 66.05% | 37.83% | 5.46% | -40.32% | -140.99% |
| Income Before Tax | 65.40% | 36.91% | 4.27% | -40.16% | -136.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 65.40% | 36.91% | 4.27% | -40.16% | -136.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.40% | 36.91% | 4.27% | -40.16% | -136.18% |
| EBIT | 66.05% | 37.83% | 5.46% | -40.32% | -140.99% |
| EBITDA | 66.10% | 37.86% | 5.40% | -40.92% | -143.84% |
| EPS Basic | 66.67% | 37.93% | 7.14% | -27.27% | -87.50% |
| Normalized Basic EPS | 66.67% | 35.29% | 0.00% | -30.77% | -80.00% |
| EPS Diluted | 60.00% | 34.48% | 7.14% | -27.27% | -87.50% |
| Normalized Diluted EPS | 55.56% | 29.41% | 0.00% | -30.77% | -80.00% |
| Average Basic Shares Outstanding | 0.11% | 4.78% | 9.91% | 16.93% | 24.93% |
| Average Diluted Shares Outstanding | 5.08% | 7.38% | 9.91% | 16.93% | 24.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |